Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 154 pseudogene (RNU7-154P) is one of many pseudogenes related to the U7 small nuclear RNA family[2][5]. U7 snRNA itself is a small nuclear RNA component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is essential for the 3' end processing of replication-dependent histone pre-mRNAs in animals[5]. However, the RNU7-154P pseudogene is categorized as non-coding and is not believed to produce functional RNA or protein[2][5]. Pseudogenes generally arise from gene duplication or retrotransposition and usually lack regulatory elements essential for expression and function[4][5]. While some pseudogenes can have regulatory "decoy" functions by sequestering microRNAs or affecting gene expression, there is no evidence that RNU7-154P exhibits such activity[4][6]. No clinical relevance, disease associations, or potential as a therapeutic target have been reported for this pseudogene[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 154 pseudogene (RNU7-154P).